Regenxbio Inc (RGNX)
Debt-to-capital ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 311,742 | 516,195 | 764,298 | 377,753 | 450,197 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2023 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $311,742K)
= 0.00
Regenxbio Inc has consistently maintained a debt-to-capital ratio of 0.00% over the past five years, indicating that the company has not utilized debt as a source of financing. This suggests that Regenxbio has been primarily relying on equity to fund its operations and growth initiatives. A debt-to-capital ratio of 0.00% signifies that the company's capital structure is not leveraged, and it is not exposed to the risks associated with high levels of debt. While a zero debt-to-capital ratio can be a positive indicator of financial stability and risk management, it is essential to consider the potential limitations of relying solely on equity financing, such as a higher cost of equity and limited financial flexibility. It may be prudent for Regenxbio to periodically evaluate its capital structure to ensure it is optimally balanced for achieving long-term growth and sustainability.
Peer comparison
Dec 31, 2023